KPTI vs PEG · rev $68.5M vs P/E 18, rev $6.40B
Karyopharm Therapeutics Inc (KPTI) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported PEG revenue for 2026-06-30 was $6.40B. Net income was $1.07B. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
KPTI currently screens at market cap $205.6M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the KPTI and PEG stock pages for the full models.
Not investment advice.